Enrolling by invitation NCT05314426
Mayo Clinic Phage Program Biobank
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Bacteriophage Therapy. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The purpose of this study is to help scientists and clinicians discover answers to research questions related to antibiotic-resistant bacterial infections, and the role that phage therapy plays as a possible treatment.
Primary outcome measures
- Enrollment of study participants [Time frame: 5 years]
- Collection of biospecimens [Time frame: 5 years]
- Medical record review [Time frame: 5 years]
- Increase treatment options and level of care for patients with bacterial infections [Time frame: 5 years]
Eligibility criteria
Inclusion criteria
- ≥ 18 years of age.
- Able to provide informed consent.
- Individual must have a future treatment plan to receive or has historically received phage therapy.
Exclusion criteria
- Individuals , 18 years of age.
- Unwilling/unable to provide informed consent.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- Mayo Clinic Rochester — Rochester
Identifiers
NCT: NCT05314426 · 21-013112